Risk factors for major bleeding in patients with non-valvular atrial fibrillation and CKD G3-G5D on oral anticoagulants

被引：0
|
作者：
Welander, Frida [1 ]
Renlund, Henrik [2 ]
Sjalander, Anders [3 ]
机构：
[1] Umea Univ, Dept Publ Hlth & Clin Med, Dept Res & Dev Sundsvall, Umea, Sweden
[2] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[3] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.066
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
430
引用
收藏
页数：2
相关论文
共 50 条
  • [21] New anticoagulants in patients with non-valvular atrial fibrillation
    Zellerhoff, S.
    Lewalter, T.
    Eckardt, L.
    Treszl, A.
    Wegscheider, K.
    Breithardt, G.
    NERVENHEILKUNDE, 2012, 31 (11) : 813 - 820
  • [22] Effect and risk of novel oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation
    Kawada, Tomoyuki
    JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 99 - 99
  • [23] ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON)
    Derosa, Giuseppe
    Rizzo, Manfredi
    Brunetti, Natale Daniele
    Raddino, Riccardo
    Gavazzoni, Mara
    Pasini, Gianfranco
    Gaudio, Giovanni
    Maggi, Antonio
    D'Angelo, Angela
    De Gennaro, Luisa
    Maffioli, Pamela
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (08)
  • [24] Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation
    Destephan, C.
    Waller, A. H.
    Patel, R. J.
    Dhruvakumar, S.
    Mazza, V.
    Gerula, C.
    Maher, J.
    Kaluski, E.
    MINERVA CARDIOANGIOLOGICA, 2012, 60 (04): : 425 - 431
  • [25] Indirect Comparisons of the New Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation
    Zolfaghari, Shabnam, Jr.
    Harenberg, Job
    Marx, Svetlana
    Wehling, Martin
    BLOOD, 2012, 120 (21)
  • [26] New oral anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation
    Bosch, Montserrat
    Llop, Roser
    Lalueza, Pilar
    del Mar Villar, Maria
    MEDICINA CLINICA, 2013, 140 (05): : 229 - 231
  • [27] Inappropriate Dosing of Oral Anticoagulants among Patients With Non-Valvular Atrial Fibrillation
    Shrestha, Sulena
    Baser, Onur
    Zhou, Xinxiang
    Kwong, W. J.
    STROKE, 2017, 48
  • [28] Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation
    Masotti, Luca
    Di Napoli, Mario
    Ageno, Walter
    Imberti, Davide
    Becattini, Cecilia
    Paciaroni, Maurizio
    Godoy, Daniel Augustin
    Cappelli, Roberto
    Landini, Giancarlo
    Panigada, Grazia
    Iori, Ido
    Prisco, Domenico
    Agnelli, Giancarlo
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 8 - 21
  • [29] Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients
    Campos-Staffico, Alessandra M. M.
    Dorsch, Michael P. P.
    Barnes, Geoffrey D. D.
    Zhu, Hao-Jie
    Limdi, Nita A. A.
    Luzum, Jasmine A. A.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Direct oral anticoagulants in non-valvular atrial fibrillation: accuracy of traditional bleeding scores in the elderly
    Novello, S.
    Graceffa, A.
    Ninivaggi, C.
    Greco, G. I.
    Bonfante, F.
    Di Stasio, F.
    Zambotti, E.
    Zorzi, A.
    Tavian, T.
    Sartori, M.
    Occhipinti, G.
    Granziera, S.
    Nante, G.
    Sergi, G.
    Manzato, E.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3864 - 3864
12345